10-Q
Quarterly Report
BIO KEY INTERNATIONAL INC
BKYI
NASDAQ
CIK: 1019034
File #: 1-13463
Balance Sheet
38 line items · 2 periods
XBRL
| Item | Jun 30, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Cash and cash equivalents | 1,260,351 | 511,400 |
Accounts receivable, net | 904,046 | 1,201,526 |
Due from factor | 28,164 | 99,320 |
Inventory | 433,182 | 445,740 |
Prepaid expenses and other | 388,786 | 364,171 |
Total current assets | 3,014,529 | 2,622,157 |
Equipment and leasehold improvements, net | 174,419 | 220,177 |
Capitalized contract costs, net | 348,617 | 229,806 |
Operating lease right-of-use assets | 9,341 | 36,905 |
Approximation | 9,341 | 36,905 |
Intangible assets, net | 1,252,090 | 1,407,990 |
Total non-current assets | 1,784,467 | 1,894,878 |
TOTAL ASSETS | 4,798,996 | 4,517,035 |
LIABILITIES | ||
Accounts payable | 1,539,548 | 1,316,014 |
Accrued liabilities | 1,164,681 | 1,305,848 |
Senior Secured Promissory Note | 2,010,293 | 0 |
Government Loan | 135,400 | 138,730 |
Deferred revenue, current | 715,193 | 414,968 |
Operating lease liabilities, current portion | 9,570 | 37,829 |
Total current liabilities | 5,574,685 | 3,213,389 |
Deferred revenue, long term | 142,949 | 28,296 |
Deferred tax liability | 22,998 | 22,998 |
Government loan – BBVA Bank – net of current portion | 114,656 | 188,787 |
Total non-current liabilities | 280,603 | 240,081 |
TOTAL LIABILITIES | 5,855,288 | 3,453,470 |
STOCKHOLDERS’ EQUITY | ||
Common stock — authorized, 170,000,000 shares; issued and outstanding; 1,815,618 and 1,032,777 of $.0001 par value at June 30, 2024 and December 31, 2023, respectively | 182 | 103 |
Additional paid-in capital | 126,143,205 | 126,047,851 |
Accumulated other comprehensive loss | (15,234) | 22,821 |
Accumulated deficit | (127,184,445) | (125,007,210) |
TOTAL STOCKHOLDERS’ EQUITY | (1,056,292) | 1,063,565 |
Common Stock | 182 | 103 |
Additional Paid-in Capital | 126,143,205 | 126,047,851 |
AOCI Attributable to Parent | (15,234) | 22,821 |
Retained Earnings | (127,184,445) | (125,007,210) |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 4,798,996 | 4,517,035 |